from the fast evolving subject of oncology investigation, exact and efficient mutation screening is essential for establishing targeted therapies. The KRAS solutions System plays a pivotal role With this landscape by providing complete answers for KRAS mutation profiling and analysis. KRAS mutations, located in approximately 95% of RAS-linked oncog